financetom
Business
financetom
/
Business
/
AerCap Q2 Earnings, Revenue Rise; Updates 2024 Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AerCap Q2 Earnings, Revenue Rise; Updates 2024 Guidance
Aug 1, 2024 1:45 AM

04:19 AM EDT, 08/01/2024 (MT Newswires) -- AerCap Holdings N.V ( AER ) reported Thursday Q2 earnings of $2.28 per diluted share, up from $2.12 per share a year earlier.

Three analysts polled by Capital IQ expected $2.09 per share.

Revenue for the quarter ended June 30 was $1.96 billion, up from $1.92 billion a year earlier.

Analysts polled by Capital IQ expected $1.9 billion.

For 2024, the company now expects adjusted earnings to range from $9.20 to $10.25 per share, compared with the previous guidance of $9.20 per share. Analysts polled by Capital IQ are expecting $10.51 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Freehold Royalties Maintained at Outperform at BMO Following Texas Acquisition; Price Target Kept at C$15.00
Freehold Royalties Maintained at Outperform at BMO Following Texas Acquisition; Price Target Kept at C$15.00
Dec 16, 2024
11:54 AM EST, 12/16/2024 (MT Newswires) -- BMO Capital Markets on Monday reiterated its market-perform rating on the shares of Freehold Royalties ( FRHLF ) and its C$15.00 price target after the company acquired royalty and mineral-title properties in the Midland Basin of Texas. FRU offers investors a high-margin, low-debt, and risk-averse way to gain exposure to the North American...
T2 Biosystems Extends Capital Equipment Supplier Deal With Vizient; Shares Rise
T2 Biosystems Extends Capital Equipment Supplier Deal With Vizient; Shares Rise
Dec 16, 2024
12:00 PM EST, 12/16/2024 (MT Newswires) -- T2 Biosystems ( TTOO ) said Monday it extended its multiyear capital equipment supplier agreement with Vizient until March 31, 2026. The contract covers products such as the T2Dx instrument, the T2Bacteria panel and the T2Candida panel, which detect sepsis-causing bacterial and fungal pathogens directly from whole blood, the company said. T2 Biosystems...
Ametek 2025 Estimates Raised on 'Improving Macro Tailwinds,' BofA Says
Ametek 2025 Estimates Raised on 'Improving Macro Tailwinds,' BofA Says
Dec 16, 2024
11:58 AM EST, 12/16/2024 (MT Newswires) -- Ametek's ( AME ) 2025 estimates have been raised, driven by improving tailwinds in macro environment and potential upside from mergers and acquisitions, BofA Securities said in a report Monday. BofA now forecasts 10% year-over-year adjusted EPS growth for 2025, reaching $7.50, which is 4% higher than consensus. This assumes 5.3% organic revenue...
NCino Revenue Likely to Grow at 15% CAGR Through 2028, UBS Says
NCino Revenue Likely to Grow at 15% CAGR Through 2028, UBS Says
Dec 16, 2024
11:49 AM EST, 12/16/2024 (MT Newswires) -- NCino's ( NCNO ) revenue is expected to increase at a roughly 15% compound annual growth rate through 2028 as it pursues a global market opportunity worth more than $18 billion, UBS Securities said Monday. The company's attractive financial profile is underpinned by highly recurring subscription revenue with [nearly] 140% subscription revenue retention...
Copyright 2023-2026 - www.financetom.com All Rights Reserved